Goserelin: all 102 studies that test it

Page 1 of 2. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.

• ADT De-escalation in Selected High-Risk Prostate Cancer Patients (ADaPPt Trial) a GROUQ Led PCS Study (PCS XIV)Not yet recruitingNCT07777263Phase 3
• Clinical Study on the Preservation of Ovarian Function Following Autologous Hematopoietic Stem Cell Transplantation Using GoserelinNot yet recruitingNCT07552493Not applicable
• Clinical Study on the Preservation of Ovarian Function Following Hematopoietic Stem Cell Transplantation in Patients With Malignant Hematologic Diseases Using GoserelinNot yet recruitingNCT07552480Not applicable
• Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer PatientsRecruitingNCT07460752Phase 2
• A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast CancerRecruitingNCT07310420Phase 1
• Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS TrialRecruitingNCT07158021Phase 2
• Adaptions and Resiliency to Multi-Stressor OpeRationsRecruitingNCT06455969Phase 4
• To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate CancerRecruitingNCT06385847Phase 2
• Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After SurgeryRecruitingNCT06348134Phase 2
• Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular TracersRecruitingNCT06282588Phase 2/3
• Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer PatientsRecruitingNCT06225284Phase 2
• To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or MifepristoneNot yet recruitingNCT05898321Not applicable
• Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624RecruitingNCT05781217Phase 3
• SNF Platform Study of HR+/ HER2-advanced Breast CancerRecruitingNCT05594095Phase 2
• Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant TherapyRecruitingNCT05582499Phase 2
• Prevention of Chemotherapy-Induced Ovarian Failure With Goserelin in Premenopausal Lymphoma PatientsEnrolling by invitationNCT04536467Phase 2
• Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence ScoreRecruitingNCT02476786Phase 2
• Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast CancerCompletedNCT03839823Phase 2Results posted
• Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate CancerActive, not recruitingNCT03361735Phase 2Results posted
• Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicityCompletedNCT02518191Phase 3Results posted
• Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast CancerTerminatedNCT01776008Phase 2Results posted
• Bipolar Androgen-based Therapy for Prostate Cancer (BAT)CompletedNCT01750398Phase 2Results posted
• The Influence of Adjuvant Medical Treatment of Peritoneal Endometriosis on the Outcome of IVF. A Prospective Randomized Analysis.CompletedNCT01682642Phase 4Results posted
• Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast CancerCompletedNCT01073865Phase 3Results posted
• Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical ProstatectomyTerminatedNCT00937768Phase 2Results posted
• Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate CancerActive, not recruitingNCT00544830Phase 2Results posted
• Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer PatientsCompletedNCT00432172Phase 2Results posted
• Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast CancerTerminatedNCT00429403Phase 3Results posted
• External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate CancerTerminatedNCT00388804Phase 3Results posted
• Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal WomenCompletedNCT00322348Phase 2Results posted
• Maximal Suppression of the Androgen Axis in Clinically Localized Prostate CancerCompletedNCT00298155Phase 2Results posted
• Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal WomenCompletedNCT00186121Phase 2Results posted
• Dose-Response of Gonadal Steroids and Bone Turnover in Older MenCompletedNCT00114114Not applicableResults posted
• S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast CancerCompletedNCT00068601Phase 3Results posted
• Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate CancerCompletedNCT00002597Phase 3Results posted
• Effect of a GnRH Analog on Hepatic SteatosisActive, not recruitingNCT06523530Phase 4
• (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast CancerActive, not recruitingNCT05607004Phase 2
• This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.Status unknownNCT05438810Phase 3
• Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate CancerStatus unknownNCT05212857Phase 2
• Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and LetrozoleCompletedNCT05163106Phase 2
• Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance TrialActive, not recruitingNCT05050084Phase 3
• Goserline Acetate VS Dienogest in EndometriosiStatus unknownNCT05013242Phase 4
• Study of Efficacy, Safety, and Pharmacokinetics of FCN-437c in Combination With Fulvestrant or Letrozole+GoserelinStatus unknownNCT05004142Phase 2
• Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate CancerActive, not recruitingNCT05003752Phase 1/2
• Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE)Active, not recruitingNCT04551495Phase 2
• COMPARISON OF A NEW FORMULATION OF GOSERELIN (Pepti 3.6 mg) to Zoladex® 3.6 mgCompletedNCT04428684Phase 1
• Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer PatientsStatus unknownNCT04248621Phase 4
• Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate CancerCompletedNCT04060043Early Phase 1
• A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.TerminatedNCT03971110Phase 4
• Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast CancerTerminatedNCT03936933Phase 3
• Goserelin 10.8mg Injection in Treatment of Advanced Prostate CancerCompletedNCT03936218Phase 3
• To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer.WithdrawnNCT03658213Phase 3
• Fulvestrant in Metastatic Breast CancerStatus unknownNCT03591549Phase 4
• Goserelin for Ovarian Protection in Premenopausal Patients Receiving CyclophosphamideStatus unknownNCT03475758Phase 2
• Neoadjuvant Goserelin for Triple Negative Breast CancerStatus unknownNCT03444025Phase 2
• Androgen Deprivation Therapy Muscle Protein Metabolism and Blood GlucoseTerminatedNCT03440879Not applicable
• Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast CancerStatus unknownNCT03373708Phase 2/3
• Systemic Hormones and Muscle Protein SynthesisStatus unknownNCT03054168Phase 3
• Reproductive Outcome of EM Treated by GnRH-a Associated With LaparoscopyStatus unknownNCT02779387Not applicable
• Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for DepressionCompletedNCT02661789Not applicable
• Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node MetastasesActive, not recruitingNCT02603679Phase 2
• Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast CancerCompletedNCT02483767Phase 3
• High-Dose Brachytherapy in Treating Patients With Prostate CancerCompletedNCT02346253Not applicable
• A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast CancerCompletedNCT02333370Phase 1
• Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced AmenorrhoeaStatus unknownNCT02132390Phase 3
• Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and GoserelinTerminatedNCT01738724Phase 4
• Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast CancerCompletedNCT01712893Phase 3
• Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast CancerCompletedNCT01530607Phase 3
• Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal WomenStatus unknownNCT01266213Phase 2
• MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast CancerWithdrawnNCT01240928Phase 1
• Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With ChemotherapyWithdrawnNCT00888082Phase 3
• Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular AtrophyCompletedNCT00851461Phase 4
• Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate CancerCompletedNCT00849082Phase 3
• Zoladex Plus Tamoxifen in Breast CancerCompletedNCT00827307Not applicable
• Radiation Therapy and Hormone Therapy in Treating Patients With Prostate CancerCompletedNCT00769548Phase 3
• Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate CancerCompletedNCT00767286Phase 3
• Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine FibroidsCompletedNCT00746031Phase 4
• Randomized Study of Gonadotropin-releasing-hormone Agonist (GnRH-a) or Expectant Management for EndometriosisStatus unknownNCT00654524Phase 4
• RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local SurgeryCompletedNCT00541047Phase 3
• Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate CancerCompletedNCT00536653Not applicable
• Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBCCompletedNCT00532272Phase 2
• Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast CancerTerminatedNCT00498901Phase 2
• A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast CancerStatus unknownNCT00488722Not applicable
• Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical RadiotherapyCompletedNCT00439751Phase 3
• Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic SyndromeTerminatedNCT00438321Phase 1
• Insulin Sensitivity in Men With the Metabolic SyndromeSuspendedNCT00433173Not applicable
• Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast CancerCompletedNCT00427245Phase 3
• Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate CancerCompletedNCT00423475Phase 3
• Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate CancerCompletedNCT00349557Phase 2
• Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive PatientsCompletedNCT00309478Phase 3
• Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal PatientsCompletedNCT00303524Phase 2
• FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate CancerStatus unknownNCT00293670Phase 4
• CMAB vs IMAB in Metastatic Prostate CancerWithdrawnNCT00255268Phase 4
• S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast CancerWithdrawnNCT00217659Phase 2
• Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)CompletedNCT00196846Phase 2
• Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate CancerCompletedNCT00067015Phase 3
• Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast CancerCompletedNCT00031850Not applicable
• Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate CancerCompletedNCT00021450Phase 3
• Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate CancerTerminatedNCT00014586Phase 3
• Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or PeritoneumCompletedNCT00012090Phase 2

← Goserelin overview